Globus Medical Inc - A (NYSE:GMED) Screens Well as a GARP Stock with Strong Growth and Reasonable Valuation
Globus Medical (GMED) fits the GARP strategy with strong growth, reasonable valuation, excellent financial health, and profitability. A compelling affordable growth stock.
Read the full article4h agoen
You might also wanna read
2 Fast-Growing Pharmaceutical Stocks to Buy Now
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.
Bars·1d ago
This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?
This company's recovery efforts are bearing fruit.
Bars·2d ago
This medtech stock is trading at a discount to peers. BTIG says it's a buy
Medtronic's shares are cheap relative to those of its competitors, making now a good time to add the stock to one's portfolio, per BTIG.
cnbc.com·1mo ago3 Stocks to Buy and Hold: The Long-Term Play for Your Portfolio
These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.
Bars·4d ago
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom
Don't sleep on these medical device leaders.
Bars·2d ago
Pharma stocks are showing strength. Charts predict this name could break out next
Pharmaceutical stocks have recently separated themselves from the broader market, and the group has become a source of leadership within hea
cnbc.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.